NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients - Archive ouverte HAL
Poster De Conférence Année : 2021

NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients

Fichier non déposé

Dates et versions

hal-03831768 , version 1 (27-10-2022)

Identifiants

Citer

Corinna Preuße, Pascale Eede, Lucie Heinzeling, Kiara Freitag, Randi Koll, et al.. NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients. 12th European Congress of Neuropathology virtual, May 2021, NA, Sweden. 40 (07), pp.149, 2021, ⟨10.5414/NPP40M01⟩. ⟨hal-03831768⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

More